FDA Inspection 984855 — Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc. — FEI 3006568549

The FDA completed an inspection of Alexion Pharmaceuticals, Inc. on August 3, 2016 in Smithfield, RI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 3, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Smithfield, RI (United States)